| RSS
Business center
Office
Post trade leads
Post
Rank promotion
Ranking
 
You are at: Home » Sell » supply

Browse by Category

APIs (3264) Intermediates (3827) Pharmaceutical Excipients (331) Plant extracts (1037) Pharmaceutical Equipment (508)
Other (395)
 
 
    Price  Image  VIP     
 
Tadalafil
  • Tadalafil
  • A medication used for the treatment of male erectile dysfunction. A phosphodiesterase 5 (PDE5) inhibitor.https://www.boc
  • 2020-06-16 15:39  Pharmaceutical Excipients
  • [United States of America]   BOC Sciences  [Not verified]
Negotiable

 
Irinotecan
  • Irinotecan
  • Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 M and 5.17 M, respectively. I
  • 2020-06-16 15:38  Pharmaceutical Excipients
  • [United States of America]   BOC Sciences  [Not verified]
Negotiable

 
Remdesivir
  • Remdesivir
  • Remdesivir, an analog nucleotide inhibitor, with effectively antiviral activity in vitro against various virus, includin
  • 2020-06-16 15:36  Pharmaceutical Excipients
  • [United States of America]   BOC Sciences  [Not verified]
Negotiable

 
Carfilzomib
  • Carfilzomib
  • Carfilzomib is a tetrapeptide epoxyketone and an analog of epoxomicin, acting as a selective proteasome inhibitor, such
  • 2020-06-16 15:34  Pharmaceutical Excipients
  • [United States of America]   BOC Sciences  [Not verified]
Negotiable

 
Cangrelor
  • Cangrelor
  • Cangrelor, an adenylic acid derivative, has been found to be a P2Y12 inhibitor that could be effective in some coronary
  • 2020-06-16 15:33  Pharmaceutical Excipients
  • [United States of America]   BOC Sciences  [Not verified]
Negotiable

 
Pentagastrin
Negotiable

 
PCI-27483
  • PCI-27483
  • PCI-27483 is a reversible small-molecule inhibitor of activated factor VII (factor VIIa) with potential antineoplastic a
  • 2020-06-16 15:32  Pharmaceutical Excipients
  • [United States of America]   BOC Sciences  [Not verified]
Negotiable

 
Rupintrivir
  • Rupintrivir
  • Rupintrivir is a potent and selective irreversible human rhinovirus (HRV) 3C protease inhibitor (EC50 = 5 nM). It has be
  • 2020-06-16 15:31  Pharmaceutical Excipients
  • [United States of America]   BOC Sciences  [Not verified]
Negotiable

 
Ipamorelin
  • Ipamorelin
  • Ipamorelin is a ghrelin mimetic displaying growth hormone (GH) releasing activity. Ipamorelin binds to ghrelin receptor
  • 2020-06-16 15:30  Pharmaceutical Excipients
  • [United States of America]   BOC Sciences  [Not verified]
Negotiable

 
Foxy-5
  • Foxy-5
  • A Wnt5a peptide mimetic. It has been undergoing clinical trials for the treatment of prostate cancer, colorectal cancer,
  • 2020-06-16 15:30  Pharmaceutical Excipients
  • [United States of America]   BOC Sciences  [Not verified]
Negotiable

 
Etarfolatide
Negotiable

 
Argireline
  • Argireline
  • Argireline is a syntheticpeptide as a fragment of SNAP-25, a substrate of Botulinum toxin (Botox). A cosmetic formulatio
  • 2020-06-16 15:29  Pharmaceutical Excipients
  • [United States of America]   BOC Sciences  [Not verified]
Negotiable

 
Brilacidin
  • Brilacidin
  • An investigational antibiotic effective against Gram positive and Gram negative bacteria, which is a non-peptide small m
  • 2020-06-16 15:26  Pharmaceutical Excipients
  • [United States of America]   BOC Sciences  [Not verified]
Negotiable

 
Xanthohumol
Negotiable

 
1% 3% 5% 9% cordyceps militaris extract cordycepin extract powder polysaccharide cordycepin
Negotiable

 
Ginsenoside-Rg5
Negotiable

 
Cycloastragenol
Negotiable

 
Astragaloside IV
Negotiable

 
Ginsenoside Rg3
Negotiable

 
Ginsenoside Rg1
Negotiable

 
Ginsenoside Rb1
Negotiable

 
Dextran 200
1.00/kg
25kgFrom the set

 
Dextran 500
1.00/kg
25kgFrom the set

 
Iron Dextran powder 25%, 35%, 38%(any Spec.)
4.00/KG
25KGFrom the set

 
Iron Dextran 10%
4.00/kg
25kgFrom the set

 
Iron Dextran 20% Solution
4.00/KG
25KGFrom the set

 
Iron Dextran 25% powder
4.00/KG
25KGFrom the set

 
Iron Dextran38% powder
4.00/KG
25KGFrom the set

 «   1   2   …   85   86   87   88   89   …   334   335   »   Total9357Article/335Page 
    Go Top     Search 

 
Weekly Search
 
Browse by Location
Beijing Shanghai
Tianjin Chongqing
Hebei Shanxi
Neimenggu Liaoning
Jilin Heilongjiang
Jiangsu Zhejiang
Anhui Fujian
Jiangxi Shandong
Henan Hubei
Hunan Guangdong
Guangxi Hainan
Sichuan Guizhou
Yunnan Xizang
Shanxi Gansu
Qinghai Ningxia
Xinjiang Taiwan
Xianggang Aomen
haiwai United States of America
Zimbabwe Zambia
Albania Dem Rep of Congo
Algeria Denmark
Angola Dominican Rep.
Anguilla Dominica (Commonwealth of)
Argentina Ecuador
Armenia Egypt
Aruba El Salvador
Australia Eritrea
Austria Estonia
Azerbaijan Ethiopia
Bahamas Fiji
Bahrain Finland
Bangladesh French Polynesia
France Barbados
Gabon Belarus
Georgia Belgium
Germany Belize
Ghana Benin
Gibraltar Bermuda
United Kingdom of Great Britain and Northern Irela Bhutan
Greece Bolivia
Grenada Bosnia and Herzegovina
Guatemala Botswana
Guinea Brazil
Guyana Brunei Darussalam
Haiti Bulgaria
Honduras Burkina Faso
Hong Kong Burundi
Hungary Cambodia
Iceland Cameroon
India Canada
Indonesia Cape Verde
Iran Cayman Islands
Iraq Central African Rep
Ireland Chad
Israel Chile
Italy China (People's Rep)
Jamaica Colombia
Japan Congo(Rep)
Jordan Cook Islands
Kenya Costa Rica
Korea (Rep) Cote d'Ivoire (Rep)
Kuwait Croatia
Lao People's Dem Rep Cyprus
Latvia Czech (Rep)
Lesotho Luxembourg
Saint Lucia Macao
Saint Vincent and the Grenadines Macedonia
Sao Tome and Principe Madagascar
Saudi Arabia Malawi
Senegal Malaysia
Seychelles Maldives
Sierra Leone Mali
Singapore Malta
Slovakia Mauritius
Slovenia Mauritania
Solomon Islands Mexico
Somalia Moldova
South Africa Mongolia
Spain Morocco
Sri Lanka Myanmar
Sudan Namibia
Suriname Nauru
Swaziland Nepal
Sweden Netherlands
Switzerland New Caledonia
Syrian Arab Rep New Zealand
Tanzania Niger
Thailand Nigeria
Togo Norway
Trinidad and Tobago Oman
Tunisia Pakistan
Turkey Panama
Uganda Papua New Guinea
Ukraine Paraguay
United Arab Emirates Peru
Philippines Uruguay
Poland Venezuela
Portugal Viet Nam
Qatar Western Samoa
Romania Yemen
Russian Federation Yugoslavia
Rwanda
 
 
Home | About | Service | copyright | agreement | contact | about | SiteMap | Links | GuestBook | Ads service | 京ICP 68975478-1
Tel:+86-10-68645975           Fax:+86-10-68645973
E-mail:yaoshang68@163.com     QQ:1483838028